Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Next generation AAV-F capsid gene therapy rescues disease pathology in a model of pyruvate dehydrogenase complex deficiency.

Molecular therapy. Advances·2026
Same author

Safety and efficacy analysis of in vivo lentiviral gene therapy in pre-clinical ARC syndrome models.

Nature communications·2026
Same author

AAV9-mediated targeting of natural antisense transcript as a novel treatment for Dravet syndrome.

Molecular therapy. Nucleic acids·2026
Same author

Contaminating plasmid sequences and disrupted vector genomes in the liver following adeno-associated virus gene therapy.

Nature medicine·2026
Same author

Genetic therapies for neurological diseases.

Pharmacological reviews·2025
Same author

Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice.

Journal of visualized experiments : JoVE·2025

Related Experiment Video

Updated: May 21, 2026

Intracerebroventricular Viral Injection of the Neonatal Mouse Brain for Persistent and Widespread Neuronal Transduction
10:15

Intracerebroventricular Viral Injection of the Neonatal Mouse Brain for Persistent and Widespread Neuronal Transduction

Published on: September 15, 2014

Vector systems for prenatal gene therapy: choosing vectors for different applications.

Charles Coutelle1, Simon N Waddington

  • 1National Heart and Lung Institute, Molecular and Cellular Medicine Section, Imperial College London, London, UK. c.coutelle@imperial.ac.uk

Methods in Molecular Biology (Clifton, N.J.)
|June 1, 2012
PubMed
Summary

Choosing the right gene therapy vector is crucial for prenatal treatments. This review compares four main systems, emphasizing versatility for diverse prenatal gene therapy applications.

More Related Videos

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants
09:20

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants

Published on: October 18, 2022

Related Experiment Videos

Last Updated: May 21, 2026

Intracerebroventricular Viral Injection of the Neonatal Mouse Brain for Persistent and Widespread Neuronal Transduction
10:15

Intracerebroventricular Viral Injection of the Neonatal Mouse Brain for Persistent and Widespread Neuronal Transduction

Published on: September 15, 2014

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants
09:20

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants

Published on: October 18, 2022

Area of Science:

  • Reproductive Medicine and Genetics
  • Molecular Biology and Gene Therapy

Background:

  • Prenatal gene therapy holds promise for treating genetic disorders before birth.
  • Effective vector systems are essential for successful in utero gene delivery.

Purpose of the Study:

  • To provide a comparative review of gene therapy vector systems used in prenatal research.
  • To highlight the importance of vector versatility for specific prenatal gene therapy aims.

Main Methods:

  • Review of existing literature on gene therapy vectors in prenatal applications.
  • Analysis of key characteristics of four major gene therapy vector systems.
  • Compilation of examples of successful prenatal gene therapy experiments using these vectors.

Main Results:

  • Identified four primary categories of gene therapy vectors.
  • Detailed the distinct characteristics and applications of each vector type.
  • Demonstrated successful prenatal gene therapy outcomes with various vector systems.

Conclusions:

  • Vector selection in prenatal gene therapy requires careful consideration of the study's objectives.
  • A versatile range of vector systems is available, each with unique advantages for in utero gene transfer.
  • The choice of vector system directly impacts the success of prenatal gene therapy interventions.